{"id":"https://openalex.org/W2166896554","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2926","title":"A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2","display_name":"A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2","publication_year":2013,"publication_date":"2013-03-20","ids":{"openalex":"https://openalex.org/W2166896554","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2926","mag":"2166896554","pmid":"https://pubmed.ncbi.nlm.nih.gov/23515411"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-12-2926","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2926","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-2926","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618599","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086403929","display_name":"Beata Holkova","orcid":"https://orcid.org/0000-0002-2486-4730","observed_orcids":["https://orcid.org/0000-0002-2486-4730"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Beata Holkova","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089509810","display_name":"Jeffrey G. Supko","orcid":"https://orcid.org/0000-0002-4599-3267","observed_orcids":["https://orcid.org/0000-0002-4599-3267"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey G. Supko","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M. Ames","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel M. Reid","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey I. Shapiro","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113843140","display_name":"Edward Brent Perkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Brent Perkins","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077796894","display_name":"Viswanathan Ramakrishnan","orcid":"https://orcid.org/0000-0002-4098-0539","observed_orcids":["https://orcid.org/0000-0002-4098-0539"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viswanathan Ramakrishnan","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091632652","display_name":"Mary Beth Tombes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Beth Tombes","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086757658","display_name":"Connie Honeycutt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Connie Honeycutt","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110580704","display_name":"Renee M. McGovern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee M. McGovern","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074048193","display_name":"Maciej Kmieciak","orcid":"https://orcid.org/0000-0002-0889-5529","observed_orcids":["https://orcid.org/0000-0002-0889-5529"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maciej Kmieciak","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109190804","display_name":"Ellen Shrader","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Shrader","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046179693","display_name":"Martha D. Wellons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha D. Wellons","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111519143","display_name":"Heidi M. Sankala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Sankala","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058783843","display_name":"Austin Doyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Austin Doyle","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Wright","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101776165","display_name":"John D. Roberts","orcid":"https://orcid.org/0000-0003-2020-6201","observed_orcids":["https://orcid.org/0000-0003-2020-6201"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Roberts","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]},{"raw_affiliation_string":"Dana-Farber/Harvard Cancer Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061036144","display_name":"Steven Grant","orcid":"https://orcid.org/0000-0003-4452-9320","observed_orcids":["https://orcid.org/0000-0003-4452-9320"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven Grant","raw_affiliation_strings":["Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massey Cancer Center; Departments of 2Internal Medicine, 3Biostatistics, 4Microbiology and Immunology, and 5Biochemistry and Molecular Biology, and 6The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, Virginia; 7Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 8Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota; and 9Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5061036144","https://openalex.org/A5086403929"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I136199984","https://openalex.org/I184840846","https://openalex.org/I4210134579","https://openalex.org/I4210140884","https://openalex.org/I4390039279"],"apc_list":null,"apc_paid":null,"fwci":2.9736,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.91395613,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"7","first_page":"1873","last_page":"1883"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9301999807357788,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.996999979019165},{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.8169999718666077},{"id":"https://openalex.org/keywords/relapsed-leukemia","display_name":"relapsed leukemia","score":0.6940000057220459},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8820000290870667},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8069999814033508},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8159999847412109},{"id":"https://openalex.org/keywords/p21-induction","display_name":"p21 induction","score":0.7200000286102295},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/rna-polymerase-ii","display_name":"RNA polymerase II","score":0.7149999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.8502185344696045},{"id":"https://openalex.org/C3018572732","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Refractory anemia","level":4,"score":0.7574853897094727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6718718409538269},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.5440652966499329},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5089704990386963},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5028945803642273},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4727155566215515},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.4629228115081787},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3708003759384155},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33860617876052856},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.11554065346717834},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.08421331644058228},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06114387512207031},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000077337","descriptor_name":"Vorinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077337","descriptor_name":"Vorinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077337","descriptor_name":"Vorinostat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000754","descriptor_name":"Anemia, Refractory, with Excess of Blasts","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012319","descriptor_name":"RNA Polymerase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012319","descriptor_name":"RNA Polymerase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012319","descriptor_name":"RNA Polymerase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-12-2926","doi":"https://doi.org/10.1158/1078-0432.ccr-12-2926","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-2926","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:23515411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23515411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:europepmc.org:2948869","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/articles/PMC3618599","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3618599","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618599","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3618599","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618599","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6399999856948853}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1016094800","display_name":null,"funder_award_id":"M01-RR-00065","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G1346863275","display_name":null,"funder_award_id":"R01-CA93738","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G27062282","display_name":null,"funder_award_id":"U01CA69912","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3436056085","display_name":null,"funder_award_id":"R21 CA115260","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3518617075","display_name":null,"funder_award_id":"R01 CA093738","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5087919879","display_name":null,"funder_award_id":"U01CA069912","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5594074728","display_name":null,"funder_award_id":"P30 CA60516","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5966678231","display_name":"General Clinical Research Center","funder_award_id":"M01RR000065","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G6567765281","display_name":null,"funder_award_id":"23XS026","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G883206123","display_name":null,"funder_award_id":"P30CA15083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000866180","display_name":"Mayo Clinic Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA015083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000888536","display_name":"Massey Cancer Center -\u00a0Cancer Center Support Grant","funder_award_id":"P30CA016059","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W1495058242","https://openalex.org/W1510956999","https://openalex.org/W1515542254","https://openalex.org/W1515666340","https://openalex.org/W1527674890","https://openalex.org/W1527712367","https://openalex.org/W1638855221","https://openalex.org/W1812576394","https://openalex.org/W1913480813","https://openalex.org/W1919339218","https://openalex.org/W1943486034","https://openalex.org/W1967018540","https://openalex.org/W1967784191","https://openalex.org/W1974478882","https://openalex.org/W1981492171","https://openalex.org/W1989819905","https://openalex.org/W2006450622","https://openalex.org/W2008868978","https://openalex.org/W2014080346","https://openalex.org/W2017898416","https://openalex.org/W2022285476","https://openalex.org/W2032167699","https://openalex.org/W2053504914","https://openalex.org/W2066107979","https://openalex.org/W2070433411","https://openalex.org/W2078619764","https://openalex.org/W2081567150","https://openalex.org/W2085553407","https://openalex.org/W2097555718","https://openalex.org/W2098617365","https://openalex.org/W2099262276","https://openalex.org/W2107020701","https://openalex.org/W2110957729","https://openalex.org/W2111911910","https://openalex.org/W2114689998","https://openalex.org/W2115276278","https://openalex.org/W2117030526","https://openalex.org/W2121710010","https://openalex.org/W2139793858","https://openalex.org/W2140642045","https://openalex.org/W2144240156","https://openalex.org/W2154043377","https://openalex.org/W2165074091","https://openalex.org/W2167118090","https://openalex.org/W2170302386","https://openalex.org/W2171141282","https://openalex.org/W2181336523","https://openalex.org/W2244747366","https://openalex.org/W2316690030","https://openalex.org/W2331221462","https://openalex.org/W2334944174","https://openalex.org/W6630958609","https://openalex.org/W6640032184","https://openalex.org/W6640560003","https://openalex.org/W6676103088","https://openalex.org/W6676826328","https://openalex.org/W6685424526","https://openalex.org/W6690861201"],"related_works":["https://openalex.org/W2360827738","https://openalex.org/W2382944647","https://openalex.org/W2406395362","https://openalex.org/W2362902914","https://openalex.org/W2381367322","https://openalex.org/W1506281628","https://openalex.org/W4285806833","https://openalex.org/W2378814104","https://openalex.org/W4362396123","https://openalex.org/W4362395666"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"phase":[2],"I":[3],"study":[4],"was":[5,97,114],"conducted":[6],"to":[7,176,193],"identify":[8],"the":[9,39,45],"maximum-tolerated":[10],"dose":[11,96],"(MTD)":[12],"of":[13,44,167,190],"alvocidib":[14,70,95,112,181,199],"when":[15],"combined":[16,66,226],"with":[17,21,32,67,134,227,246],"vorinostat":[18,51,178,228],"in":[19,132,217,236],"patients":[20,106,170,197],"relapsed,":[22],"refractory,":[23],"or":[24,29,80],"poor":[25],"prognosis":[26],"acute":[27],"leukemia,":[28],"refractory":[30],"anemia":[31],"excess":[33],"blasts-2.":[34],"Secondary":[35],"objectives":[36],"included":[37],"investigating":[38],"pharmacokinetic":[40],"and":[41,109,130,147,157,205,208],"pharmacodynamic":[42],"effects":[43],"combination.":[46],"EXPERIMENTAL":[47],"DESIGN:":[48],"Patients":[49],"received":[50],"(200":[52],"mg":[53],"orally,":[54],"three":[55],"times":[56],"a":[57,63,73,81,87,100],"day,":[58],"for":[59,212],"14":[60],"days)":[61],"on":[62,127],"21-day":[64],"cycle,":[65],"2":[68],"different":[69],"administration":[71],"schedules:":[72],"1-hour":[74],"intravenous":[75],"infusion,":[76,90],"daily":[77],"\u00d7":[78,92],"5;":[79],"30-minute":[82],"loading":[83,118],"infusion":[84],"followed":[85,120],"by":[86,121,185],"4-hour":[88],"maintenance":[89,125],"weekly":[91],"2.":[93],"The":[94,111,136],"escalated":[98],"using":[99],"standard":[101],"3+3":[102],"design.":[103],"RESULTS:":[104],"Twenty-eight":[105],"were":[107,141,153,163,183,222,243],"enrolled":[108],"treated.":[110],"MTD":[113],"20":[115,122],"mg/m(2)":[116,123],"(30-minute":[117],"infusion)":[119,126],"(4-hour":[124],"days":[128],"one":[129],"eight,":[131],"combination":[133],"vorinostat.":[135,186],"most":[137],"frequently":[138],"encountered":[139],"toxicities":[140,151],"cytopenias,":[142],"fatigue,":[143],"hyperglycemia,":[144],"hypokalemia,":[145],"hypophosphatemia,":[146],"QT":[148,158],"prolongation.":[149,159],"Dose-limiting":[150],"(DLT)":[152],"cardiac":[154],"arrhythmia-atrial":[155],"fibrillation":[156],"No":[160],"objective":[161,241],"responses":[162,221,242],"achieved":[164],"although":[165,215],"13":[166],"26":[168],"evaluable":[169],"exhibited":[171],"stable":[172],"disease.":[173],"Alvocidib":[174,225],"seemed":[175],"alter":[177],"pharmacokinetics,":[179],"whereas":[180],"pharmacokinetics":[182],"unaffected":[184],"Ex":[187],"vivo":[188,218],"exposure":[189],"leukemia":[191],"cells":[192],"plasma":[194],"obtained":[195,245],"from":[196],"after":[198],"treatment":[200],"blocked":[201],"vorinostat-mediated":[202],"p21(CIP1)":[203],"induction":[204],"downregulated":[206],"Mcl-1":[207],"p-RNA":[209],"Pol":[210],"II":[211],"some":[213,237],"specimens,":[214],"parallel":[216],"bone":[219],"marrow":[220],"infrequent.":[223],"CONCLUSIONS:":[224],"is":[229],"well":[230],"tolerated.":[231],"Although":[232],"disease":[233],"stabilization":[234],"occurred":[235],"heavily":[238],"pretreated":[239],"patients,":[240],"not":[244],"these":[247],"schedules.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}